IL-18 in atopic dermatitis—a multifaceted driver of skin inflammation
Journal of Allergy and Clinical Immunology · 2025
DOI: 10.1016/j.jaci.2025.07.025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025. Verfasst von Lukas Bähler und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Department for BioMedical Research (DBMR), U…. Hauptthemen laut MEDLINE: Interleukin-18, Dermatitis, Atopic, Skin. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: LEO Foundation, Bern Center for Precision Medicine, University of Bern, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.
Abstract (Originalsprache)
Atopic dermatitis (AD) is a common chronic inflammatory skin disease characterized by pruritus, barrier dysfunction, and immune cell infiltration. Despite significant progress in our understanding of AD pathophysiology, the molecular mechanisms driving the disease remain only partially elucidated. Recently, the cytokine IL-18, a member of the IL-1 family, has drawn attention for its involvement in diverse immune responses and potential impact on disease severity. In this review, we examine the role of IL-18 in AD, with a focus on genetic associations, biomarker potential, and cellular sources. Elevated IL-18 levels in both the skin and serum of patients with AD are positively correlated with disease severity, type 2 immune response, and impaired barrier function. Mouse models of AD reinforce the importance of IL-18, wherein neutralization or genetic knockout alleviates AD-like features. We further explore how IL-18 drives type 2 immune responses in the skin and the cellular mechanisms involved. Collectively, the present literature supports a crucial role for IL-18 in AD pathophysiology, indicating that targeting IL-18 may be a promising therapeutic strategy for managing the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland.
- BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
- Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; Department for BioMedical Research (DBMR), University of Bern, Bern, Switzerland; Department of Dermatology and Al…
Förderung
- LEO Foundation
- Bern Center for Precision Medicine, University of Bern
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Zitieren
APA
Bähler, L., Schärli, S., Luther, F., Bertschi, N. L., Skabytska, Y., Roediger, B., & Schlapbach, C. (2025). IL-18 in atopic dermatitis—a multifaceted driver of skin inflammation. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2025.07.025
Vancouver
Bähler L, Schärli S, Luther F, Bertschi NL, Skabytska Y, Roediger B, et al. IL-18 in atopic dermatitis—a multifaceted driver of skin inflammation. Journal of Allergy and Clinical Immunology. 2025. doi:10.1016/j.jaci.2025.07.025
BibTeX
@article{Bhler2025,
author = {Bähler, Lukas and Schärli, Stefanie and Luther, Fabian and Bertschi, Nicole L and Skabytska, Yuliya and Roediger, Ben and Schlapbach, Christoph},
title = {IL-18 in atopic dermatitis—a multifaceted driver of skin inflammation},
journal = {Journal of Allergy and Clinical Immunology},
year = {2025},
doi = {10.1016/j.jaci.2025.07.025}
}
EUVIMED